Zevra Therapeutics (ZVRA) Cash & Current Investments (2014 - 2026)
Zevra Therapeutics (ZVRA) reported Cash & Current Investments of $195.57 million for Q3 2026, down 2.0% from $199.51 million a year earlier and down 11.7% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Cash & Current Investments (2014 - 2026) Analysis & Trends
At the end of FY2025, Zevra Therapeutics posted Cash & Current Investments of $191.01 million, up 174.9% from FY2024.
- Cash & Current Investments has a five-year compound annual growth rate of 114.4% (FY2020 to FY2025).
- By year, Cash & Current Investments came in at $69.5 million in FY2024 (+2.6%), $67.74 million in FY2023 (-17.8%), $82.37 million in FY2022 (-26.7%) and $112.35 million in FY2021.
- Five-year quarterly Cash & Current Investments spans a low of $49.26 million in Q2 2024 and a high of $221.57 million in Q2 2026.
- Year over year, Cash & Current Investments gained in seven of the last eight quarters, with growth averaging 107.3%.
- The high point for year-over-year Cash & Current Investments in five years was Q2 2025 (growth of 311.3%); the low point was Q2 2024 (a decline of 43.3%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $221.57 million (Q2 2026), $200.62 million (Q1 2026) and $191.01 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 505.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 8.17 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 14.27 Bn |
| 10 | Zevra Therapeutics | 708.52 Mn | -100.24 Mn | 36.01 Mn | 195.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 195.57 Mn |
| Jun 30, 2026 | 221.57 Mn |
| Mar 31, 2026 | 200.62 Mn |
| Dec 31, 2025 | 191.01 Mn |
| Sep 30, 2025 | 199.51 Mn |
| Jun 30, 2025 | 202.61 Mn |
| Mar 31, 2025 | 62.63 Mn |
| Dec 31, 2024 | 69.50 Mn |
| Sep 30, 2024 | 89.38 Mn |
| Jun 30, 2024 | 49.26 Mn |
| Mar 31, 2024 | 52.72 Mn |
| Dec 31, 2023 | 67.74 Mn |
| Sep 30, 2023 | 82.94 Mn |
| Jun 30, 2023 | 86.89 Mn |
| Mar 31, 2023 | 74.58 Mn |
| Dec 31, 2022 | 82.37 Mn |
| Sep 30, 2022 | 75.89 Mn |
| Jun 30, 2022 | 80.98 Mn |
| Mar 31, 2022 | 101.58 Mn |
| Dec 31, 2021 | 112.35 Mn |
API Access
Zevra Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();